ABBV AbbVie
- Official Name: ABBVIE INC.
- Headquarters: 1 N Waukegan Rd, NORTH CHICAGO, IL, 60064 US
- CEO: Robert A. Michael
- Website: abbvie.com
- Key Investor: VANGUARD GROUP INC | 9.85%
- Dedicated Investor: LIVELSBERGER FINANCIAL ADVISORY | 41.31%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-18 | 1 | Lost by 2.207 | (0.476) - 1.731 | ||
| 2025-07-25 | 2 | Lost by 2.940 | 0.566 - 3.506 | ||
| 2025-07-29 | 2R | Won by 0.614 | 2.272 - 1.658 | ||
| 2025-08-01 | 3 | Won by 11.730 | 2.032 - (9.698) | ||
| 2025-08-07 | 1R | Won by 0.838 | 1.321 - 0.483 | ||
| 2025-08-08 | 4 | Won by 2.815 | 4.828 - 2.013 | ||
| 2025-08-12 | 3R | Lost by 1.996 | (0.913) - 1.083 | ||
| 2025-08-15 | 5 | Won by 4.691 TOTW | 5.345 - 0.654 | ||
| 2025-08-20 | 1R | Won by 2.500 | 1.521 - (0.979) | ||
| 2025-08-21 | 2R | Lost by 2.166 | 0.257 - 2.423 | ||
| 2025-08-22 | 6 | Won by 1.330 | 1.715 - 0.385 | ||
| 2025-08-29 | 7 | Lost by 2.417 | (0.062) - 2.355 | ||
| 2025-09-03 | 2R | Won by 1.017 | (0.028) - (1.045) | ||
| 2025-09-05 | 8 | Lost by 0.428 | 0.975 - 1.403 | ||
| 2025-09-12 | 9 | Won by 3.532 | 2.886 - (0.646) | ||
| 2025-09-17 | 3R | Won by 4.204 | 2.133 - (2.071) | ||
| 2025-09-19 | 10 | Won by 0.067 | 1.810 - 1.743 | ||
| 2025-09-26 | 11 | Lost by 2.221 | (0.730) - 1.491 | ||
| 2025-10-01 | QF | Lost by 3.537 | 5.264 - 8.801 | ||
| 2025-10-03 | 12 | Won by 3.314 | 5.178 - 1.864 | ||
| 2025-10-10 | 13 | Lost by 0.085 | (1.328) - (1.243) | ||
| 2025-10-17 | 14 | Lost by 2.122 | (0.438) - 1.684 | ||
| 2025-10-24 | 15 | Lost by 2.163 | (0.664) - 1.499 |
Latest News
SeekingAlpha - 2026-08-31
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...
Show more
Benzinga - 2026-08-26
AbbVie Submits EMA Application For SKYRIZI Subcutaneous Induction In Adults With Moderately To Severely Active Crohn's Disease, Backed By Phase 3 AFFIRM Data
Benzinga - 2026-08-26
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
SeekingAlpha - 2026-08-26
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
SeekingAlpha - 2026-08-24
AbbVie Still Has Room To Run
SeekingAlpha - 2026-08-24
Sanofi: Trump's Vaccine Policy Won't Break The Story
SeekingAlpha - 2026-08-24
Best Dividend Kings: August 2026
SeekingAlpha - 2026-08-23
Wall Street Week Ahead
Yahoo - 2026-08-21
Lilly's Multiple Assumes Less Growth Than You Think
Yahoo - 2026-08-21
Most Of What Moves AbbVie Stock Has Nothing To Do With The Market
Yahoo - 2026-08-21
AbbVie (ABBV) Presented New Lung Cancer Clinical Data At WCLC 2026
Yahoo - 2026-08-21
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
Yahoo - 2026-08-21
3 Unpopular Stocks That Deserve Some Love
Benzinga - 2026-08-21
AbbVie To Present New Data From Its ABBV-1480 PD-1/VEGF Bispecific Antibody In Frontline Non-Small Cell Lung Cancer At 2026 World Conference On Lung Cancer
Yahoo - 2026-08-20
Merck Stock Ran On A Checklist Published In Advance
Yahoo - 2026-08-20
Pfizer Stock Is A Race Between New Drugs And Old Patents
Yahoo - 2026-08-20
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead
Yahoo - 2026-08-20
GKOS Stock Surges 67% Year to Date: What's Driving the Rally?
Yahoo - 2026-08-20
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
Benzinga - 2026-08-20
Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $303
Yahoo - 2026-08-20
Why Is Merck Stock Still Undervalued After An 80% Surge?
Yahoo - 2026-08-19
Johnson & Johnson Stock Runs On A Calendar The Market Does Not Set
Yahoo - 2026-08-19
Is AbbVie Stock About To Break Out Again?
Yahoo - 2026-08-19
Real Parkinson’s Disease Hope from Jupiter Neurosciences
SeekingAlpha - 2026-08-19
Novo Nordisk: The Best Value In Pharma
Benzinga - 2026-08-18
10 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-08-18
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
SeekingAlpha - 2026-08-17
5 Undervalued Winners Up To 6.8% And 15 Overvalued To Avoid Now
Benzinga - 2026-08-17
Wells Fargo Maintains Overweight on AbbVie, Raises Price Target to $300
Fintel - 2026-08-14
Wolfe Research Upgrades AbbVie (ABBV)
Yahoo - 2026-08-13
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Yahoo - 2026-08-13
Johnson & Johnson (JNJ)’s $5.5B Talc Settlement: Turning Point or Temporary Relief?
Yahoo - 2026-08-13
Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?
Yahoo - 2026-08-13
The Sharpest Exchanges From ABBV's Earnings Call
Benzinga - 2026-08-13
Wolfe Research Upgrades AbbVie to Outperform, Announces $300 Price Target
SeekingAlpha - 2026-08-13
American Century Focused Global Growth Fund Q2 2026 Portfolio Review
Yahoo - 2026-08-12
How ABBV Stock Moved Away From Its Peer Group
Yahoo - 2026-08-12
Amgen Stock And The Price Of A Promise
Yahoo - 2026-08-12
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield
Yahoo - 2026-08-12
The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is
Yahoo - 2026-08-11
JNJ Keeps Climbing. Should You Climb On?
Yahoo - 2026-08-11
$49 Billion In Payouts, A Lagging Stock: The PFE Trade-Off
Yahoo - 2026-08-11
AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There?
Yahoo - 2026-08-11
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-08-11
How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?
Benzinga - 2026-08-11
BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247
Yahoo - 2026-08-11
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices
Yahoo - 2026-08-11
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
Yahoo - 2026-08-10
What Analysts Really Pressed LLY On This Quarter
Yahoo - 2026-08-10
AbbVie’s (ABBV) Botox Just Got A Step Closer To A Fifth Use
Yahoo - 2026-08-10
Eli Lilly Stock's Next Climb Runs Through A Pill, Not Just An Injection
Yahoo - 2026-08-10
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
Yahoo - 2026-08-10
We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks.
Benzinga - 2026-08-10
Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $260
Yahoo - 2026-08-10
3 Beaten-Down Healthcare Stocks to Buy in August
Benzinga - 2026-08-10
Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate
Yahoo - 2026-08-09
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call
Yahoo - 2026-08-07
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed
Yahoo - 2026-08-07
The Two Divergent Paths Priced Into Eli Lilly Stock
SeekingAlpha - 2026-08-07
Dividend Champion, Contender, And Challenger Highlights: Week Of August 9
Yahoo - 2026-08-07
Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
Yahoo - 2026-08-07
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
Yahoo - 2026-08-07
REGENXBIO Q2 Earnings Call Highlights
Yahoo - 2026-08-06
Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ...
Yahoo - 2026-08-06
The 6.4% Monthly Payer That Beat JEPI by 8 Points With No NAV Bleed
Yahoo - 2026-08-06
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
Yahoo - 2026-08-06
REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
SeekingAlpha - 2026-08-06
Stock Picks From Seeking Alpha's July 2026 New Analysts
Benzinga - 2026-08-05
Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'
Yahoo - 2026-08-05
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
Yahoo - 2026-08-05
Why PFE Stock Hands You So Much Cash Right Now
SeekingAlpha - 2026-08-05
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Yahoo - 2026-08-05
Prediction: AbbVie Will End The Year at This Price
Yahoo - 2026-08-05
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Yahoo - 2026-08-04
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo - 2026-08-04
The $85 Billion Consolation Prize For JNJ Shareholders
Yahoo - 2026-08-04
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
SeekingAlpha - 2026-08-04
OPKO Health: Mazdutide And MDX-2201 Could Change Everything
Yahoo - 2026-08-04
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
Yahoo - 2026-08-04
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open
Yahoo - 2026-08-04
UBRELVY® (ubrogepant) Recommended for Reimbursement by Canada's Drug Agency (CDA-AMC) for Acute Migraine Treatment
Benzinga - 2026-08-04
'AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal' - Bloomberg
Benzinga - 2026-08-04
AbbVie's Allergan Aesthetics Receives FDA Acceptance For Review For Its Supplemental Biologics License Application For BOTOX Cosmetic
Benzinga - 2026-08-04
Guggenheim Maintains Buy on AbbVie, Raises Price Target to $288
Benzinga - 2026-08-04
AbbVie Says Canada's Drug Agency Recommends UBRELVY Be Reimbursed With Conditions By Public Drug Plans For Acute Treatment Of Migraine In Adults
Yahoo - 2026-08-04
More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not
Yahoo - 2026-08-04
‘Huh?’ Markets React to AstraZeneca’s Megadeal Talks With Bristol Myers
Yahoo - 2026-08-03
$49 Billion In Payouts, A Lagging Stock: The Pfizer Trade-Off
Yahoo - 2026-08-03
AbbVie's Growth Now Leans On A Single Molecule
Benzinga - 2026-08-03
Canaccord Genuity Maintains Buy on AbbVie, Raises Price Target to $290
Yahoo - 2026-08-03
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
Yahoo - 2026-08-03
Stocks mixed as AstraZeneca merger talk dents FTSE 100
Yahoo - 2026-08-03
What Are Wall Street Analysts' Target Price for AbbVie Stock?
Yahoo - 2026-08-03
AbbVie Pipeline Draws Greater Investor Focus After 'Strong' Q2, RBC Says
Yahoo - 2026-08-03
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
Yahoo - 2026-08-03
ABBV Q2 Earnings Call Balances Growth With Apogee Dilution
Benzinga - 2026-08-03
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus
Yahoo - 2026-08-03
3 Top Dividend Stocks to Buy Before Their Next Payout
SeekingAlpha - 2026-08-03
AbbVie: Strong Q2 And New Catalysts Keep Me Bullish
Benzinga - 2026-08-03
Cantor Fitzgerald Maintains Overweight on AbbVie, Raises Price Target to $285
Yahoo - 2026-08-02
AbbVie Quietly Solved Its Biggest Problem—Now What?
Yahoo - 2026-07-31
Why AbbVie Stock Slumped Today
Yahoo - 2026-07-31
AbbVie (ABBV) Wins EU Approval For RINVOQ In Vitiligo And Alopecia
Yahoo - 2026-07-31
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and ...
Yahoo - 2026-07-31
AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling.
SeekingAlpha - 2026-07-31
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run
Yahoo - 2026-07-31
ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down
Yahoo - 2026-07-31
AbbVie Inc. Q2 2026 Earnings Call Summary
SeekingAlpha - 2026-07-31
AbbVie Inc. (ABBV) Q2 2026 Earnings Call Transcript
Yahoo - 2026-07-31
Top Midday Stories: Apple Shares Fall on Weak Guidance; Amazon Q2 EPS Beats Estimates as AWS Sales Surge
Benzinga - 2026-07-31
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
Yahoo - 2026-07-31
AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition
Yahoo - 2026-07-31
Earnings Data Deluge
Yahoo - 2026-07-31
AbbVie Q2 Earnings Call Highlights
Yahoo - 2026-07-31
AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition
Yahoo - 2026-07-31
Pre-Market Trading Up in Final Session of the Week
Yahoo - 2026-07-31
The Signs Before Eli Lilly Stock Surged Were All On The Record
Yahoo - 2026-07-31
LLY Stock: Collect 12% Now, In Exchange For Capping Upside At 15%
Yahoo - 2026-07-31
AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Benzinga - 2026-07-31
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion
Benzinga - 2026-07-31
Moleculin Biotech Stock Is Sinking Friday: What's Going On?
Yahoo - 2026-07-31
AbbVie Q2 2026 earnings: profit forecast cut for Apogee deal
Yahoo - 2026-07-31
AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue
Yahoo - 2026-07-31
AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates
Yahoo - 2026-07-31
Update: Amazon Overperformance Lifts US Equity Futures Pre-Bell Amid Potential Expansion of Middle East Conflict to Egypt
ChartMill - 2026-07-31
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
Yahoo - 2026-07-31
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It’s Cutting Earnings Guidance.
Yahoo - 2026-07-31
AbbVie shares fall on earnings miss and weak guidance
ChartMill - 2026-07-31
AbbVie (NYSE:ABBV) Shares Slip on Apogee Acquisition Despite In-Line Q2 Results
Yahoo - 2026-07-31
Stocks Rise Pre-Bell as Amazon Results Lift AI Trade Sentiment
Benzinga - 2026-07-31
Conference Call: AbbVie Sees Q3 Adj EPS $3.84-$3.88 vs $3.84 Est; Sees Sales $17.200B vs $17.322B Est
Benzinga - 2026-07-31
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat
Benzinga - 2026-07-31
AbbVie Exec Says Now Expect Total Annual Net Revenue Of ~$67.6B, Increase Of $300M Versus Previous Forecast
Benzinga - 2026-07-31
CORRECTION: AbbVie Lowers FY2026 Adj EPS Guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 Est
Benzinga - 2026-07-31
AbbVie Q2 Adj. EPS $3.65 Beats $3.60 Estimate, Sales $16.990B Beat $16.765B Estimate
Yahoo - 2026-07-30
Friday's market movers: Oil earnings and consumer sentiment data
Yahoo - 2026-07-30
What To Expect From AbbVie’s (ABBV) Q2 Earnings
ChartMill - 2026-07-30
Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays
Yahoo - 2026-07-30
JUVÉDERM® Day Returns to U.S. on August 19
Yahoo - 2026-07-29
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
Yahoo - 2026-07-29
The Real Price of AbbVie Stock Is Cheaper Than You Think
Yahoo - 2026-07-29
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
Yahoo - 2026-07-29
AbbVie (ABBV) Stock May Be Mispriced On Its 172% Run
Benzinga - 2026-07-29
Barclays Maintains Overweight on AbbVie, Raises Price Target to $300
Yahoo - 2026-07-29
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Yahoo - 2026-07-29
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
Benzinga - 2026-07-29
Rick Scott Warns Beijing's New Drug Rules Could Threaten US Medicine Supply: 'Stop Being Dependent on Communist China'
Yahoo - 2026-07-28
Goldman Sachs uncovers key AbbVie stock signals before earnings
Benzinga - 2026-07-28
AbbVie's RINVOQ Wins European Commission Approval For Non-Segmental Vitiligo, First Systemic Medication Approved In EU For This Condition
Yahoo - 2026-07-28
What Johnson & Johnson Stock Told You Before It Surged
Yahoo - 2026-07-28
Does Eli Lilly Stock Actually Diversify Your Portfolio?
Yahoo - 2026-07-28
Botox Maker Tops Buy Point, But Here Comes The Earnings Report
Yahoo - 2026-07-28
3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st
Yahoo - 2026-07-28
Should You Buy, Hold or Sell ABBV Stock Ahead of Q2 Earnings?
Yahoo - 2026-07-28
Prediction: This ‘Boring’ Dividend ETF Secretly Rides the AI Trade and Out-Earns Your High-Yield Fund by 2036
Yahoo - 2026-07-28
Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?
Yahoo - 2026-07-28
Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SeekingAlpha - 2026-07-28
Incyte: From Buy To Hold After A 93% Rally (Rating Downgrade)
Yahoo - 2026-07-27
Should You Buy AbbVie Stock Hand Over Fist Before July 31?
Yahoo - 2026-07-27
The Engine Behind ABBV Stock Has Real Parts
Yahoo - 2026-07-27
UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch
Yahoo - 2026-07-27
Collect 9.8% On LLY Stock Now, Own It 30% Cheaper If It Dips
Yahoo - 2026-07-27
S&P 500 Second-Quarter Earnings Growth Reaches 70%, Oppenheimer Says
Yahoo - 2026-07-27
Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck
Yahoo - 2026-07-27
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
Yahoo - 2026-07-27
Johnson & Johnson Now Leads Its Pitch With An Oncology Bet
SeekingAlpha - 2026-07-26
Best Dividend Kings: July 2026
Yahoo - 2026-07-26
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
Yahoo - 2026-07-25
Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?
Yahoo - 2026-07-25
Why Wall Street Can't Get Enough of This Dividend King
Yahoo - 2026-07-25
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
SeekingAlpha - 2026-07-25
Big Tech Earnings, Fed's Interest Rate Decision To Keep Next Week Busy
Yahoo - 2026-07-24
SpaceX Lands With a Thud
Yahoo - 2026-07-24
J&J's Innovative Medicine Unit Proves Its Resilience in Q2
Yahoo - 2026-07-24
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
SeekingAlpha - 2026-07-24
AbbVie: A Dividend Fortress At An Appealing Price Tag
Benzinga - 2026-07-24
Netflix, AbbVie, Cerebras Systems And An Energy Stock On CNBC’s ‘Final Trades’
Benzinga - 2026-07-24
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
Yahoo - 2026-07-23
HDV Delivers 3.1% Yield While Beating SPY Year to Date by 9 Points
Yahoo - 2026-07-23
Best Monthly Dividend ETFs for Consistent Income
Benzinga - 2026-07-23
From The ETF Professor: NFLX content deal helps SKYY, cloud computing ETF, hit high of the day. NFLX 6.6% of ETF's weight
SeekingAlpha - 2026-07-23
AbbVie: Bright Future, But Already Priced In
Yahoo - 2026-07-23
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower
Yahoo - 2026-07-22
Will AbbVie's Oncology Franchise Remain Under Pressure in Q2?
Yahoo - 2026-07-22
LLY Has Momentum. The Question Is The Price
SeekingAlpha - 2026-07-22
IGD: Attractive Yield, But Discount Is Smaller Than Normal
Benzinga - 2026-07-22
Synchrony Financial To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga - 2026-07-22
Canaccord Genuity Maintains Buy on AbbVie, Raises Price Target to $282
Yahoo - 2026-07-21
How Investors May Respond To AbbVie (ABBV) Securing EU Approval For Short-Acting Boey Aesthetic Toxin
Yahoo - 2026-07-21
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
Yahoo - 2026-07-21
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
Yahoo - 2026-07-21
Eli Lilly Stock And The Price Of Confidence
Yahoo - 2026-07-21
AbbVie Stock Zigs When The Market Zags
SeekingAlpha - 2026-07-21
Going Deeper On Disc Medicine
Yahoo - 2026-07-21
Biotech IPOs Surge 55% as AI Listings Lose Momentum
Yahoo - 2026-07-21
Biotech IPO Gains Crush AI Listings With Standout 55% Return
Yahoo - 2026-07-21
Psychedelic drugs are going mainstream
Yahoo - 2026-07-20
Reading Between The Lines Of JNJ Stock's Latest Call
Benzinga - 2026-07-20
Clinical Trial Results Show Extended Benefits for REGENXBIO Retinal Treatments
Yahoo - 2026-07-20
What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.
SeekingAlpha - 2026-07-19
Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data
Yahoo - 2026-07-19
My 2 Favorite Dividend Kings to Buy Right Now
Yahoo - 2026-07-19
3 Biggest Pharma Giants: Buy, Sell or Hold?
Yahoo - 2026-07-18
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Yahoo - 2026-07-17
The Real Question Buried Inside Merck Stock's Premium Price
Yahoo - 2026-07-17
AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe
Yahoo - 2026-07-17
VYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way
Benzinga - 2026-07-17
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
SeekingAlpha - 2026-07-17
Where To Invest Now In AI, Biotech, Small Caps, And Gold
Benzinga - 2026-07-17
Allergan Aesthetics' Boey Receives European Commission Approval To Treat Moderate To Severe Lines Between The Eyebrows
Yahoo - 2026-07-16
Why Healthcare Stocks Look Like a Haven in This Market
Yahoo - 2026-07-16
Will AbbVie's Neuroscience Franchise Deliver Another Strong Quarter?
SeekingAlpha - 2026-07-16
I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade)
Yahoo - 2026-07-16
Abbott Laboratories Q2 Earnings Call Highlights
Yahoo - 2026-07-16
Why Abbott Stock Is Having Its Best Day in 24 Years
Benzinga - 2026-07-16
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
Yahoo - 2026-07-16
What Could Push LLY Stock Higher From Here?
Yahoo - 2026-07-16
The Real Engine Behind Johnson & Johnson Stock's Next Climb
Yahoo - 2026-07-16
Why Abbott Earnings Are Sending the Stock Higher
Yahoo - 2026-07-15
Johnson & Johnson CFO Says This Drug Is Outperforming ‘Almost Any Launch’ in Recent Memory
Yahoo - 2026-07-15
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
Yahoo - 2026-07-15
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
Yahoo - 2026-07-15
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates
Benzinga - 2026-07-15
Citigroup Maintains Neutral on AbbVie, Raises Price Target to $260
Yahoo - 2026-07-14